Grand Canyon Education Faces Lawsuit as Iovance Stock Plunges on Trial Halt; Ethereum in Focus on Upgrade and ETF Prospects
• Grand Canyon Education share price rising, but on lower trading volumes recently; faces lawsuit over alleged deceptive practices • Iovance stock plunged 18% as FDA halted trial of its lung cancer cell therapy after patient death • Ethereum gained 6% as investors anticipate network upgrade and potential spot ETF approval in January • Ethereum price broke out above a pennant, typically signaling trend continuation • Key technical levels to monitor for Grand Canyon Education, Iovance, and Ethereum highlighted